Inhaler treatment options in COPD

被引:80
作者
Newman, S. P.
机构
关键词
Chronic obstructive pulmonary disease; dry powder inhaler; pressurised metereddose inhaler; soft mist inhaler; spacer device;
D O I
10.1183/09059180.05.00009605
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
A variety of inhaler devices are available for delivering treatments to patients with chronic obstructive pulmonary disease, and new inhalers are currently being developed. Each type of device has advantages and disadvantages, and the methods of preparation and use vary between them. The differences in instructions for use can easily confuse patients and health providers alike, resulting in incorrect use of many inhalers. "Crucial'' errors in inhaler technique, whereby no drug is deposited in the lungs, must be avoided. Any type of inhaler can be misused so that little or no drug is deposited in the lungs. It is now increasingly widely recognised that a successful treatment outcome in chronic obstructive pulmonary disease depends as much on the inhaler device as it does on the drug. Inhaler choice in chronic obstructive pulmonary disease should take into account whether the patient is likely to use it correctly, as well as patient preference and the likelihood of adherence to treatment.
引用
收藏
页码:102 / 108
页数:7
相关论文
共 46 条
[1]   Efficacy and safety of inhaled corticosteroids - New developments [J].
Barnes, PJ ;
Pedersen, S ;
Busse, WW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (03) :S1-S53
[2]   THE EFFECT OF DELAY, MULTIPLE ACTUATIONS AND SPACER STATIC CHARGE ON THE IN-VITRO DELIVERY OF BUDESONIDE FROM THE NEBUHALER [J].
BARRY, PW ;
OCALLAGHAN, C .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 40 (01) :76-78
[3]   On the use of dry powder inhalers in situations perceived as constrained [J].
Borgström, L .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2001, 14 (03) :281-287
[4]   True device compliance: the need to consider both competence and contrivance [J].
Brennan, VK ;
Osman, LM ;
Graham, H ;
Critchlow, A ;
Everard, ML .
RESPIRATORY MEDICINE, 2005, 99 (01) :97-102
[5]  
Byron Peter R, 2004, Proc Am Thorac Soc, V1, P321, DOI 10.1513/pats.200403-023MS
[6]   Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper [J].
Celli, BR ;
MacNee, W ;
Agusti, A ;
Anzueto, A ;
Berg, B ;
Buist, AS ;
Calverley, PMA ;
Chavannes, N ;
Dillard, T ;
Fahy, B ;
Fein, A ;
Heffner, J ;
Lareau, S ;
Meek, P ;
Martinez, F ;
McNicholas, W ;
Muris, J ;
Austegard, E ;
Pauwels, R ;
Rennard, S ;
Rossi, A ;
Siafakas, N ;
Tiep, B ;
Vestbo, J ;
Wouters, E ;
ZuWallack, R .
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) :932-946
[7]   METHOD OF USING PRESSURIZED AEROSOLS [J].
CONNOLLY, CK .
BRITISH MEDICAL JOURNAL, 1975, 3 (5974) :21-21
[8]  
CROMPTON GK, 1982, EUR J RESPIR DIS, V63, P101
[9]   A review of the development of Respimat® Soft Mist™ Inhaler [J].
Dalby, R ;
Spallek, M ;
Voshaar, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 283 (1-2) :1-9
[10]  
Derom E, 2002, LUNG BIOL HEALTH DIS, V162, P143